BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG
55 results:

  • 1. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
    Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
    Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. pparg activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
    Schöckel L; Woischke C; Surendran SA; Michl M; Schiergens T; Hölscher A; Glass F; Kreissl P; Klauschen F; Günther M; Ormanns S; Neumann J
    BMC Cancer; 2024 Feb; 24(1):234. PubMed ID: 38378472
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal cancer at MRI.
    Xia W; Li D; He W; Pickhardt PJ; Jian J; Zhang R; Zhang J; Song R; Tong T; Yang X; Gao X; Cui Y
    Radiol Artif Intell; 2024 Mar; 6(2):e230152. PubMed ID: 38353633
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. colorectal cancer and Precursor Lesion Prevalence in Adults Younger Than 50 Years Without Symptoms.
    Penz D; Waldmann E; Hackl M; Jiricka L; Rockenbauer LM; Gessl I; Zessner-Spitzenberg J; Ferlitsch A; Trauner M; Ferlitsch M
    JAMA Netw Open; 2023 Dec; 6(12):e2334757. PubMed ID: 38055281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 3
    Tu J; Meng X; Wang J; Han Z; Yu Z; Sun H
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834468
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway.
    Shang K; Ma N; Che J; Li H; Hu J; Sun H; Cao B
    BMC Cancer; 2023 Apr; 23(1):335. PubMed ID: 37041476
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and
    Tan Y; Kang J; Li H; Zhong A; Liu Y; Zhang Z; Huang R; Cheng X; Peng W
    Front Immunol; 2023; 14():1149810. PubMed ID: 37033970
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular mechanism study and tumor heterogeneity of Chinese angelica and Fructus aurantii in the treatment of colorectal cancer through computational and molecular dynamics.
    Huang H; Ke C; Zhang D; Wu J; Zhang P
    Funct Integr Genomics; 2023 Mar; 23(2):106. PubMed ID: 36977932
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Role of PPAR-gamma C161T Polymorphism in colorectal cancer Susceptibility.
    Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
    In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells.
    Saliani M; Jalal R; Javadmanesh A
    Sci Rep; 2022 May; 12(1):7965. PubMed ID: 35562390
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Simultaneous or staged resection for synchronous liver metastasis and primary rectal cancer: a propensity score matching analysis.
    Karam E; Bucur P; Gil C; Sindayigaya R; Tabchouri N; Barbier L; Pabst-Giger U; Bourlier P; Lecomte T; Moussata D; Chapet S; Calais G; Ouaissi M; Salamé E
    BMC Gastroenterol; 2022 Apr; 22(1):201. PubMed ID: 35448953
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bioinformatics and
    Qin J; Guo C; Yang L; Liang X; Jiao A; Lai KP; Yang B
    Bioengineered; 2021 Dec; 12(2):12461-12469. PubMed ID: 34931923
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated colorectal Tumorigenesis.
    Mäki-Nevala S; Ukwattage S; Wirta EV; Ahtiainen M; Ristimäki A; Seppälä TT; Lepistö A; Mecklin JP; Peltomäki P
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680073
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The expression and clinical significance of GPR39 in colon cancer.
    Wu X; Dou Y; Xu H; Jiang Z
    Ir J Med Sci; 2022 Aug; 191(4):1577-1585. PubMed ID: 34586565
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of cetuximab combined with chemotherapy in treating metastatic colorectal cancer and its prognostic analysis.
    Wu J; Wang Z; Jin C; Ren H; Hu Y; Yang B; Hu Y
    J BUON; 2021; 26(1):101-108. PubMed ID: 33721439
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diet and
    Tran L; Bobe G; Arani G; Zhang Y; Zhang Z; Shannon J; Takata Y
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477496
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pparg expression in colorectal cancer and its association with staging and clinical evolution.
    Villa ALP; Parra RS; Feitosa MR; Camargo HP; Machado VF; Tirapelli DPDC; Rocha JJRD; Feres O
    Acta Cir Bras; 2020; 35(7):e202000708. PubMed ID: 32813759
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multi-omics Analysis Reveals Adipose-tumor Crosstalk in Patients with colorectal cancer.
    Holowatyj AN; Haffa M; Lin T; Scherer D; Gigic B; Ose J; Warby CA; Himbert C; Abbenhardt-Martin C; Achaintre D; Boehm J; Boucher KM; Gicquiau A; Gsur A; Habermann N; Herpel E; Kauczor HU; Keski-Rahkonen P; Kloor M; von Knebel-Doeberitz M; Kok DE; Nattenmüller J; Schirmacher P; Schneider M; Schrotz-King P; Simon T; Ueland PM; Viskochil R; Weijenberg MP; Scalbert A; Ulrich A; Bowers LW; Hursting SD; Ulrich CM
    Cancer Prev Res (Phila); 2020 Oct; 13(10):817-828. PubMed ID: 32655010
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting colorectal cancer Cells into Differentiated Normal-Like Cells.
    Lee S; Lee C; Hwang CY; Kim D; Han Y; Hong SN; Kim SH; Cho KH
    Mol Cancer Res; 2020 Jan; 18(1):118-129. PubMed ID: 31896605
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.